CAREIUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.1 SEK | -2.90% |
|
-2.59% | +30.30% |
| May. 16 | Stefan Berg Leaves the Careium Board Due to New Role | CI |
| Apr. 25 | Transcript : Careium AB, Q1 2024 Earnings Call, Apr 25, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company appears to be poorly valued given its net asset value.
- For several months, analysts have been revising their EPS estimates roughly upwards.
Weaknesses
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Ratings chart - Surperformance
Sector: Business Support Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +30.30% | 72.47M | - | ||
| -5.02% | 13.02B | C+ | ||
| +10.22% | 6.07B | B- | ||
| -34.37% | 1.73B | - | D+ | |
| +3.18% | 1.05B | B+ | ||
| +0.93% | 877M | B | ||
| -5.43% | 714M | C | ||
| +56.60% | 531M | - | - | |
| +4.34% | 500M | - | - | |
| -31.36% | 431M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- CARE Stock
- Ratings Careium AB
